- Home
- NUKK vs RANI Comparison
NUKK vs RANI Comparison
Compare NUKK & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUKK
- RANI
- Stock Information
- Founded
- NUKK 2013
- RANI 2012
- Country
- NUKK United States
- RANI United States
- Employees
- NUKK N/A
- RANI N/A
- Industry
- NUKK Blank Checks
- RANI Medicinal Chemicals and Botanical Products
- Sector
- NUKK Finance
- RANI Health Care
- Exchange
- NUKK Nasdaq
- RANI Nasdaq
- Market Cap
- NUKK 25.4M
- RANI 23.2M
- IPO Year
- NUKK N/A
- RANI 2021
- Fundamental
- Price
- NUKK $4.78
- RANI $0.50
- Analyst Decision
- NUKK
- RANI Strong Buy
- Analyst Count
- NUKK 0
- RANI 4
- Target Price
- NUKK N/A
- RANI $7.75
- AVG Volume (30 Days)
- NUKK 9.9M
- RANI 677.7K
- Earning Date
- NUKK 11-14-2025
- RANI 08-07-2025
- Dividend Yield
- NUKK N/A
- RANI N/A
- EPS Growth
- NUKK N/A
- RANI N/A
- EPS
- NUKK N/A
- RANI N/A
- Revenue
- NUKK N/A
- RANI $1,200,000.00
- Revenue This Year
- NUKK N/A
- RANI N/A
- Revenue Next Year
- NUKK N/A
- RANI N/A
- P/E Ratio
- NUKK N/A
- RANI N/A
- Revenue Growth
- NUKK N/A
- RANI N/A
- 52 Week Low
- NUKK $1.30
- RANI $0.39
- 52 Week High
- NUKK $78.32
- RANI $3.75
- Technical
- Relative Strength Index (RSI)
- NUKK 45.87
- RANI 45.69
- Support Level
- NUKK $4.35
- RANI $0.44
- Resistance Level
- NUKK $7.19
- RANI $0.58
- Average True Range (ATR)
- NUKK 1.26
- RANI 0.04
- MACD
- NUKK 0.26
- RANI -0.01
- Stochastic Oscillator
- NUKK 18.75
- RANI 32.74
About NUKK Nukkleus Inc.
Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.